Peter A. Thompson - Insider Trading & Ownership

Entity
Individual
Location
C/O Anthera Pharmaceuticals, Inc., 25801 Industrial Boulevard, Suite B, Hayward, California
Summary
The estimated net worth of Peter A. Thompson is at least $274 M dollars as of June 24, 2024. Peter A. Thompson is the Director, 10%+ Owner of Edgewise Therapeutics, Inc. and owns shares of Edgewise Therapeutics, Inc. (EWTX) stock worth about $228 M. Peter A. Thompson is the Director of ARS Pharmaceuticals, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $30.3 M. Peter A. Thompson is the Director, 10%+ Owner of Corvus Pharmaceuticals, Inc. and owns shares of Corvus Pharmaceuticals, Inc. (CRVS) stock worth about $14.5 M. Peter A. Thompson is the Director of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $1.36 M.
All Insider Reports
All Insider Reports

Ownership of Peter A. Thompson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EWTX Edgewise Therapeutics, Inc. Director, 10%+ Owner $228 M +$5 M +2.24% Jun 10, 2024
SPRY ARS Pharmaceuticals, Inc. Director $30.3 M +$3.1 M +11.4% Jun 20, 2024
CRVS Corvus Pharmaceuticals, Inc. Director, 10%+ Owner $14.5 M +$2.5 M +20.8% Jun 13, 2024
JANX Janux Therapeutics, Inc. Director $1.36 M Jun 14, 2022
ALPN ALPINE IMMUNE SCIENCES, INC. Director $0 -$28.7 M -100% May 18, 2024
DBTX Decibel Therapeutics, Inc. Director, 10%+ Owner Jun 17, 2022
PMVP PMV Pharmaceuticals, Inc. Director, 10%+ Owner Jun 2, 2021

Insider Transactions Reported by Peter A. Thompson:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership